ATE443079T1 - Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen - Google Patents

Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen

Info

Publication number: ATE443079T1
Authority: AT; Austria
Prior art keywords: glycopeptides; lymphocytes; sequence; glycopeptide; amino acids
Prior art date: 2000-12-21

Application number

AT01991884T

Other languages

English (en)

Inventor

Gilles Marchal

Felix Romain

Pascale Pescher

Original Assignee

Pasteur Institut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-21

Filing date

2001-12-20

Publication date

2009-10-15

2001-12-20 Application filed by Pasteur Institut filed Critical Pasteur Institut

2009-10-15 Application granted granted Critical

2009-10-15 Publication of ATE443079T1 publication Critical patent/ATE443079T1/de

Links

108010015899 Glycopeptides Proteins 0.000 title abstract 9
102000002068 Glycopeptides Human genes 0.000 title abstract 9
230000002163 immunogen Effects 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
238000012216 screening Methods 0.000 title 1
150000001413 amino acids Chemical class 0.000 abstract 5
210000004698 lymphocyte Anatomy 0.000 abstract 4
DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 3
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 2
230000003053 immunization Effects 0.000 abstract 2
238000002649 immunization Methods 0.000 abstract 2
244000000010 microbial pathogen Species 0.000 abstract 2
230000007935 neutral effect Effects 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
102000004127 Cytokines Human genes 0.000 abstract 1
241000233866 Fungi Species 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
229930182470 glycoside Natural products 0.000 abstract 1
150000002338 glycosides Chemical class 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1
150000004043 trisaccharides Chemical class 0.000 abstract 1
238000002255 vaccination Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT01991884T 2000-12-21 2001-12-20 Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen ATE443079T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0016808A FR2818647B1 (fr)	2000-12-21	2000-12-21	Glycopeptides immunogenes, criblage, preparation et applications
PCT/FR2001/004100 WO2002050108A2 (fr)	2000-12-21	2001-12-20	Glycopeptides immunogenes, criblage, préparation et applications.

Publications (1)

Publication Number	Publication Date
ATE443079T1 true ATE443079T1 (de)	2009-10-15

Family

ID=8858029

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01991884T ATE443079T1 (de)	2000-12-21	2001-12-20	Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen

Country Status (10)

Country	Link
US (2)	US7361348B2 (de)
EP (1)	EP1343814B1 (de)
JP (2)	JP2004520317A (de)
AT (1)	ATE443079T1 (de)
AU (1)	AU2002231848A1 (de)
CA (1)	CA2432047A1 (de)
DE (1)	DE60139952D1 (de)
ES (1)	ES2335269T3 (de)
FR (1)	FR2818647B1 (de)
WO (1)	WO2002050108A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2818647B1 (fr) *	2000-12-21	2006-09-29	Pasteur Institut	Glycopeptides immunogenes, criblage, preparation et applications
US20080293620A1 (en) *	2004-09-30	2008-11-27	Institut Pasteur	Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections
US7820142B2 (en) *	2004-09-30	2010-10-26	Institut Pasteur	Immunogenic glycopeptides, screening, preparation and uses
US8741313B2 (en) *	2008-01-11	2014-06-03	Emory University	Polypeptide vaccine and vaccination strategy against mycobacterium
WO2012145392A2 (en) *	2011-04-18	2012-10-26	Curators Of The University Of Missouri	Saccharide conjugates
US9360470B2 (en) *	2012-06-26	2016-06-07	Centre Hospitalier Regional Universitaire De Lille	In vitro diagnostic method for an invasive fungal infection using MALDI-TOFF mass spectrometry

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US142453A (en) *		1873-09-02		Improvement in compounds for preserving wood
US5714593A (en)	1995-02-01	1998-02-03	Institut Pasteur	DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US6290969B1 (en) *	1995-09-01	2001-09-18	Corixa Corporation	Compounds and methods for immunotherapy and diagnosis of tuberculosis
EP0952849A4 (de) *	1996-12-31	2004-09-08	Univ New York	Frühe erkennung von mycobakteriellen erkrankungen
GB9904695D0 (en) *	1999-03-01	1999-04-21	Imp Cancer Res Tech	Peptide
FR2818647B1 (fr) *	2000-12-21	2006-09-29	Pasteur Institut	Glycopeptides immunogenes, criblage, preparation et applications
US7820142B2 (en)	2004-09-30	2010-10-26	Institut Pasteur	Immunogenic glycopeptides, screening, preparation and uses

2000
- 2000-12-21 FR FR0016808A patent/FR2818647B1/fr not_active Expired - Fee Related
2001
- 2001-12-20 DE DE60139952T patent/DE60139952D1/de not_active Expired - Lifetime
- 2001-12-20 ES ES01991884T patent/ES2335269T3/es not_active Expired - Lifetime
- 2001-12-20 US US10/451,323 patent/US7361348B2/en not_active Expired - Fee Related
- 2001-12-20 EP EP01991884A patent/EP1343814B1/de not_active Expired - Lifetime
- 2001-12-20 CA CA002432047A patent/CA2432047A1/fr not_active Abandoned
- 2001-12-20 AU AU2002231848A patent/AU2002231848A1/en not_active Abandoned
- 2001-12-20 JP JP2002552001A patent/JP2004520317A/ja not_active Ceased
- 2001-12-20 AT AT01991884T patent/ATE443079T1/de not_active IP Right Cessation
- 2001-12-20 WO PCT/FR2001/004100 patent/WO2002050108A2/fr not_active Ceased
2008
- 2008-02-21 US US12/034,926 patent/US7658929B2/en not_active Expired - Fee Related
2010
- 2010-04-06 JP JP2010088027A patent/JP2010235606A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
WO2002050108A3 (fr)	2002-08-29
ES2335269T3 (es)	2010-03-24
FR2818647B1 (fr)	2006-09-29
US7361348B2 (en)	2008-04-22
JP2010235606A (ja)	2010-10-21
US20040171523A1 (en)	2004-09-02
CA2432047A1 (fr)	2002-06-27
FR2818647A1 (fr)	2002-06-28
US7658929B2 (en)	2010-02-09
US20080233599A1 (en)	2008-09-25
JP2004520317A (ja)	2004-07-08
WO2002050108A2 (fr)	2002-06-27
AU2002231848A1 (en)	2002-07-01
EP1343814A2 (de)	2003-09-17
DE60139952D1 (de)	2009-10-29
EP1343814B1 (de)	2009-09-16

Legal Events

Date

Code

Title

Description

2010-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1343814

Country of ref document: EP

2011-09-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
WO2006076410A3 (en)	2007-10-25	Li-key/antigenic epitope hybrid peptide vaccines
EP2275551A3 (de)	2011-08-03	Antigenpeptide aus Neisseria
CA2202652A1 (en)	1996-04-25	Production of peptides in plants as viral coat protein fusions
JP2010512792A5 (de)	2011-02-17
CA2438080A1 (en)	2002-10-10	Gonococcal proteins and nucleic acids
CY1106875T1 (el)	2012-09-26	Αντιγονικα πεπτιδια απο neisseria
BR0213565A (pt)	2004-10-26	Anticorpo de anti-tnf alfa modificado
CA2439428A1 (en)	2002-10-24	Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
AU2003239659A1 (en)	2003-10-13	Peptide epitopes common to antigens of the same multigene family
ATE235916T1 (de)	2003-04-15	Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern
ATE282634T1 (de)	2004-12-15	Chaperonin 10
ATE443079T1 (de)	2009-10-15	Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen
ATE445015T1 (de)	2009-10-15	Verfahren zur herstellung rekombinanter, lipid- modifizierter psaa proteine und deren verwendung
FI120149B (fi)	2009-07-15	Ei tyypittävissä olevan Haemophilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle
DE69132813D1 (de)	2002-01-03	Genetisches igfbp-5 rodierendes material
EP2135876A3 (de)	2010-06-16	Zusammensetzungen aus polypeptiden-spezifischen bis pathogenen Strängen und ihre Verwendung als Impfstoffe und in der Immuntherapie
BR0309491A (pt)	2005-02-15	Composição de vacina, composição imunogênica, utilização de uma proteìna e7 e anticorpos neutralizantes
ATE189700T1 (de)	2000-02-15	Genetisches igfbp-4 rodierendes material
TW200716166A (en)	2007-05-01	Lawsonia intracellularis immunological proteins
WO2002040529A3 (en)	2003-03-20	Diastereomeric peptides and pharmaceutical compositions comprising them
ATE466876T1 (de)	2010-05-15	Immunogene konstrukte
ATE312923T1 (de)	2005-12-15	Moraxella catarrhalis basb034 polypeptide und verwendungen davon
WO2002077648A3 (en)	2003-12-31	Pathogenic and commensal vaccine antigens
WO2006113782A3 (en)	2008-08-28	Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
US20180169209A1 (en)	2018-06-21	FSBM Recombinant Protein